-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 RTAo+wiYRgAxuAC8VYhTvBltNM64FvCpNeqCDTnTKULiakayZ7uqBHi3KgGHPPI1
 etWBSMbO8LFLLvpRhoA7KA==

<SEC-DOCUMENT>0001116502-08-000909.txt : 20080606
<SEC-HEADER>0001116502-08-000909.hdr.sgml : 20080606
<ACCEPTANCE-DATETIME>20080606163422
ACCESSION NUMBER:		0001116502-08-000909
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20080604
FILED AS OF DATE:		20080606
DATE AS OF CHANGE:		20080606

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			PharmaNet Development Group Inc
		CENTRAL INDEX KEY:			0001089542
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
		IRS NUMBER:				592407464
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		504 CARNEGIE CENTER
		CITY:			PRINCETON
		STATE:			NJ
		ZIP:			08540-6242
		BUSINESS PHONE:		609-951-6800

	MAIL ADDRESS:	
		STREET 1:		504 CARNEGIE CENTER
		CITY:			PRINCETON
		STATE:			NJ
		ZIP:			08540-6242

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SFBC INTERNATIONAL INC
		DATE OF NAME CHANGE:	19990625

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			CLASSON ROLF A
		CENTRAL INDEX KEY:			0001030325

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-16119
		FILM NUMBER:		08886086

	BUSINESS ADDRESS:	
		STREET 1:		20 KINGSBRIDGE RD
		STREET 2:		C/O ENZON INC
		CITY:			PISCATAWAY
		STATE:			NJ
		ZIP:			08854
		BUSINESS PHONE:		9089804500

	MAIL ADDRESS:	
		STREET 1:		20 KINGSBRIDGE RD
		CITY:			PISCATAWAY
		STATE:			NJ
		ZIP:			08854
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>x1-56288_ex.xml
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0202</schemaVersion>

    <documentType>4</documentType>

    <periodOfReport>2008-06-04</periodOfReport>

    <notSubjectToSection16>0</notSubjectToSection16>

    <issuer>
        <issuerCik>0001089542</issuerCik>
        <issuerName>PharmaNet Development Group Inc</issuerName>
        <issuerTradingSymbol>PDGI</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001030325</rptOwnerCik>
            <rptOwnerName>CLASSON ROLF A</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O PHARMANET DEVELOPMENT GROUP, INC.</rptOwnerStreet1>
            <rptOwnerStreet2>504 CARNEGIE CENTER</rptOwnerStreet2>
            <rptOwnerCity>PRINCETON</rptOwnerCity>
            <rptOwnerState>NJ</rptOwnerState>
            <rptOwnerZipCode>08540</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>1</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>0</isTenPercentOwner>
            <isOther>0</isOther>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable>
        <nonDerivativeTransaction>
            <securityTitle>
                <value>Common Stock, Par value $.001</value>
            </securityTitle>
            <transactionDate>
                <value>2008-06-04</value>
            </transactionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>A</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
            </transactionCoding>
            <transactionAmounts>
                <transactionShares>
                    <value>7654</value>
                    <footnoteId id="F1"/>
                </transactionShares>
                <transactionPricePerShare>
                    <value>16.33</value>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>A</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>16502</value>
                    <footnoteId id="F2"/>
                    <footnoteId id="F3"/>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </nonDerivativeTransaction>
    </nonDerivativeTable>

    <footnotes>
        <footnote id="F1">Represents shares which were acquired through the automatic grant of $125,000 worth of restricted stock units, granted
 pursuant to the Company's 1999 Stock Plan, upon election to the Board of Directors at the Annual Meeting of Stockholders
 held on June 4, 2008, determined by using the closing price on June 4, 2008. These restricted stock units vest according to
 the terms of the grant.</footnote>
        <footnote id="F2">Such amount represents: (i) 7,654 shares of restricted stock units, and (ii) 8,848 shares of common stock.</footnote>
        <footnote id="F3">Mr. Classon has elected to defer receipt of his restricted stock units for tax planning purposes.</footnote>
    </footnotes>

    <ownerSignature>
        <signatureName>/s/ John P. Hamill (Attorney-in-Fact)</signatureName>
        <signatureDate>2008-06-05</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----